| Targeting the translation machinery in cancer M Bhat, N Robichaud, L Hulea, N Sonenberg, J Pelletier, I Topisirovic Nature reviews Drug discovery 14 (4), 261-278, 2015 | 838 | 2015 |
| eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression L Furic, L Rong, O Larsson, IH Koumakpayi, K Yoshida, A Brueschke, ... Proceedings of the National Academy of Sciences 107 (32), 14134-14139, 2010 | 597 | 2010 |
| Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3 N Robichaud, SV del Rincon, B Huor, T Alain, LA Petruccelli, J Hearnden, ... Oncogene 34 (16), 2032-2042, 2015 | 276 | 2015 |
| Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases BW Konicek, JR Stephens, AM McNulty, N Robichaud, RB Peery, ... Cancer research 71 (5), 1849-1857, 2011 | 247 | 2011 |
| Translational control in cancer N Robichaud, N Sonenberg, D Ruggero, RJ Schneider Cold Spring Harbor perspectives in biology 11 (7), a032896, 2019 | 220 | 2019 |
| Translational control of the activation of transcription factor NF-κB and production of type I interferon by phosphorylation of the translation factor eIF4E B Herdy, M Jaramillo, YV Svitkin, AB Rosenfeld, M Kobayashi, D Walsh, ... Nature immunology 13 (6), 543-550, 2012 | 128 | 2012 |
| Translational control in the tumor microenvironment promotes lung metastasis: Phosphorylation of eIF4E in neutrophils N Robichaud, BE Hsu, R Istomine, F Alvarez, J Blagih, EH Ma, ... Proceedings of the National Academy of Sciences 115 (10), E2202-E2209, 2018 | 94 | 2018 |
| Beyond antibiotic resistance: integrating conjugative elements of the SXT/R391 family that encode novel diguanylate cyclases participate to c‐di‐GMP signalling in Vibrio cholerae E Bordeleau, E Brouillette, N Robichaud, V Burrus Environmental microbiology 12 (2), 510-523, 2010 | 94 | 2010 |
| Translational control and the cancer cell response to stress N Robichaud, N Sonenberg Current opinion in cell biology 45, 102-109, 2017 | 74 | 2017 |
| Phosphorylation of eIF4E confers resistance to cellular stress and DNA-damaging agents through an interaction with 4E-T: a rationale for novel therapeutic approaches A Martinez, M Sese, JH Losa, N Robichaud, N Sonenberg, T Aasen, ... PloS one 10 (4), e0123352, 2015 | 48 | 2015 |
| Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis C Zakaria, P Sean, HD Hoang, LP Leroux, M Watson, ST Workenhe, ... PLoS Pathogens 14 (8), e1007264, 2018 | 27 | 2018 |
| microRNA-induced translational control of antiviral immunity by the cap-binding protein 4EHP X Zhang, C Chapat, P Wang, JH Choi, Q Li, J Luo, S Wiebe, SH Kim, ... Molecular cell 81 (6), 1187-1199. e5, 2021 | 26 | 2021 |
| 4E-BP–Dependent Translational Control of Irf8 Mediates Adipose Tissue Macrophage Inflammatory Response D Pearl, S Katsumura, M Amiri, N Tabatabaei, X Zhang, V Vinette, X Pang, ... The Journal of Immunology 204 (9), 2392-2400, 2020 | 15 | 2020 |
| eIF4E and its binding proteins N Robichaud, N Sonenberg Translation and Its Regulation in Cancer Biology and Medicine, 73-113, 2014 | 7 | 2014 |
| nELISA: A high-throughput, high-plex platform enables quantitative profiling of the secretome M Dagher, G Ongo, N Robichaud, J Kong, W Rho, I Teahulos, A Tavakoli, ... bioRxiv, 2023.04. 17.535914, 2023 | 5 | 2023 |
| Abstract LB-302: eIF4E phosphorylation is Mnk-dependent but does not require assembly of the eIF4F translation initiation complex C Hall, C Dumstorf, B Konicek, N Robichaud, A McNulty, S Parsons, ... Cancer Research 74 (19_Supplement), LB-302-LB-302, 2014 | 3 | 2014 |
| Colorectal Cancers A Parsyan, N Robichaud, S Meterissian Translation and Its Regulation in Cancer Biology and Medicine, 593-610, 2014 | 2 | 2014 |
| Treatment-Specific Immune Phenotypes Identified by nELISA High-Throughput Proteomics Reveal Actionable Insights for Drug Discovery N Robichaud, G Ongo, I Teahulos, W Rho, M Dagher CANCER IMMUNOLOGY RESEARCH 11 (12), 2023 | | 2023 |
| Abstract A029: Treatment-Specific Immune Phenotypes Identified by nELISA High-Throughput Proteomics Reveal Actionable Insights for Drug Discovery N Robichaud, G Ongo, I Teahulos, W Rho, M Dagher Cancer Immunology Research 11 (12_Supplement), A029-A029, 2023 | | 2023 |
| 61 Treatment-specific immune phenotypes in PBMCs revealed by nELISA high-throughput proteomics N Robichaud, G Ongo, W Rho, I Teahulos, M Dagher Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
